Chondroitin polymerizing factor predicts a poor prognosis and promotes breast cancer progression via the upstream TGF-ß1/SMAD3 and JNK axis activation.

Pan, Qiang-Feng; Ouyang, Wei-Wei; Zhang, Meng-Qi; He, Shuo; Yang, Si-Yun; Zhang, Jun

Pan, Qiang-Feng; Ouyang, Wei-Wei; Zhang, Meng-Qi; He, Shuo; Yang, Si-Yun; Zhang, Jun.

Affiliation

Pan QF; Department of Pathology, Guizhou Medical University, Guiyang, 550004, China.
Ouyang WW; Department of Oncology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China.
Zhang MQ; Department of Pathology, Guizhou Medical University, Guiyang, 550004, China.
He S; Department of Pathology, Guizhou Medical University, Guiyang, 550004, China.
Yang SY; Department of Pathology, Guizhou Medical University, Guiyang, 550004, China.
Zhang J; Department of Pathology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, China. zhangjun8989@gmc.edu.cn.

J Cell Commun Signal ; 17(1): 89-102, 2023 Mar.

Article de En | MEDLINE | ID: mdl-36042157

Mots clés

CHPF; Human breast cancer; JNK signaling; MDA-MB-231 cell line; SMAD3 signaling; TGF-ß1

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: J Cell Commun Signal Année: 2023 Type de document: Article Pays d'affiliation: Chine Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google